Intra-Cellular Therapies, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
COLL
Collegium Pharmaceutical, Inc. |
$29.14 | $935.98 M | 23.87 | 357 |
AQST
Aquestive Therapeutics, Inc. |
$2.71 | $269.68 M | -4.68 | 142 |
IRWD
Ironwood Pharmaceuticals, Inc. |
$0.60 | $102.09 M | -3.32 | 253 |
ANIP
ANI Pharmaceuticals, Inc. |
$58.72 | $1.27 B | -49.81 | 897 |
DCPH
Deciphera Pharmaceuticals, Inc. |
$25.59 | $2.21 B | -11.58 | 355 |
EGRX
Eagle Pharmaceuticals, Inc. |
$1.90 | $19.44 M | 1.76 | 134 |
NBIX
Neurocrine Biosciences, Inc. |
$123.02 | $12.24 B | 41.77 | 1800 |
DVAX
Dynavax Technologies Corporation |
$9.79 | $1.17 B | -19.54 | 405 |
PCRX
Pacira BioSciences, Inc. |
$25.84 | $1.20 B | -11.58 | 788 |
ALKS
Alkermes plc |
$30.61 | $5.05 B | 14.57 | 1800 |
AMPH
Amphastar Pharmaceuticals, Inc. |
$25.71 | $1.21 B | 9.32 | 2028 |
CYTH
Cyclo Therapeutics, Inc. |
$0.72 | $23.59 M | -0.8 | 8 |
AMRX
Amneal Pharmaceuticals, Inc. |
$7.32 | $3.37 B | -183 | 8300 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
